Shares in Sun Pharmaceutical Industries Ltd
"Doxil generic approval came in as a positive surprise. This would add US$70-$100m in high margin sales for FY14 until further generic competition comes in," CLSA said in a note on Tuesday.
Shares in the drugmaker also gained after subsidiary Taro Pharmaceutical Industries Ltd
Sun Pharma shares were up 3.5 percent as of 12:28 p.m.